Intra-Cellular Therapies, Inc.

What is Intra-Cellular Therapies, Inc. (ITCI) stock price today?

As of Apr 2, 2025, 8:00 PM UTC, Intra-Cellular Therapies, Inc. (ITCI) stock is trading at $131.87. The stock price is quoted in USD and refreshes in real-time throughout the trading day. AlphaPilot provides live market data powered by Financial Modeling Prep's institutional-grade API, ensuring you get accurate and up-to-date ITCI stock quotes for informed trading decisions.

What is Intra-Cellular Therapies, Inc.'s market capitalization?

Intra-Cellular Therapies, Inc. (ITCI) has a market capitalization of approximately $14.0B. Market cap is calculated by multiplying the current share price by the total number of outstanding shares. This valuation metric helps investors compare Intra-Cellular Therapies, Inc.'s size relative to other companies in the USD market. The market cap figure updates automatically as the ITCI stock price changes.

What is the 52-week range for Intra-Cellular Therapies, Inc. stock?

Intra-Cellular Therapies, Inc. (ITCI) stock has traded in a 52-week range of $64.09 — $131.98. The 52-week range shows the highest and lowest prices at which ITCI traded over the past year, helping investors assess price volatility and identify potential support and resistance levels. Comparing the current Intra-Cellular Therapies, Inc. stock price to this range provides context for recent price action.

How much trading volume does Intra-Cellular Therapies, Inc. stock have?

Intra-Cellular Therapies, Inc. (ITCI) stock recently traded approximately 16M shares. Trading volume indicates market liquidity and investor interest in ITCI. Higher volume typically suggests active participation and can signal important price movements or news catalysts affecting Intra-Cellular Therapies, Inc. stock.

Does Intra-Cellular Therapies, Inc. pay dividends to shareholders?

Yes, Intra-Cellular Therapies, Inc. (ITCI) currently offers a dividend yield of approximately 0%. Dividend yield is calculated by dividing the company's annual dividend payments by the current stock price, expressed as a percentage. This metric helps income-focused investors evaluate Intra-Cellular Therapies, Inc. stock's potential for generating passive income. Dividend data reflects the trailing twelve months (TTM) of distributions.

What is Intra-Cellular Therapies, Inc.'s intraday price range?

Today, Intra-Cellular Therapies, Inc. (ITCI) stock has traded in a range of $131.87 — $131.87. The intraday range represents the lowest and highest prices reached during the current trading session. Monitoring ITCI's intraday volatility helps traders identify entry and exit points, while comparing it to the 52-week range provides perspective on short-term versus long-term price movements.

Where does AlphaPilot get Intra-Cellular Therapies, Inc. stock data?

AlphaPilot sources real-time ITCI stock quotes, fundamental financial data, and historical price charts for Intra-Cellular Therapies, Inc. from Financial Modeling Prep's institutional-grade API. This enterprise data feed provides live market prices during trading hours, along with comprehensive fundamentals that update after each earnings release, SEC filing, or corporate action. The Intra-Cellular Therapies, Inc. stock summary page combines intraday price movements with key metrics like P/E ratio, market cap, dividend yield, and balance sheet data to give investors a complete view of ITCI stock performance.